Skip to main content
NVDA-0.69%AAPL+0.50%GOOGL+1.34%MSFT+2.72%AMZN-0.62%TSM+0.60%SPCX-2.25%AVGO+2.77%TSLA-0.63%META+0.54%LLY+0.50%SKHY+13.30%BRK-B-0.49%MU-2.54%WMT-0.46%AMD+3.24%JPM+1.05%XOM+1.17%V-0.31%JNJ+0.86%ASMLa+1.33%MA+0.08%ABBV-0.14%INTC+1.91%1398.HK+2.46%CVX+0.46%0700.HK-1.52%ORCL+10.58%COST-0.95%CSCO-0.98%KO+0.60%PG-0.61%UNH-0.80%1816.HK-24.73%BAC+0.34%3988.HK+1.86%AMAT+5.07%AP2d+4.38%CAT+0.01%0857.HK+3.02%LRCX+5.39%HD-0.30%PM+0.01%0939.HK+2.47%DELL-1.64%GE+1.17%1288.HK+1.81%0005.HK+0.34%MS+1.81%HSBA.L+0.09%AUDNZD+1.65%NZDCAD-1.54%NZDUSD-1.38%GBPNZD+1.01%NZDCHF-0.98%EURNZD+0.87%NZDJPY-0.83%AUDJPY+0.82%EURAUD-0.76%CADJPY+0.73%AUDCHF+0.67%EURCAD-0.64%GBPAUD-0.64%USDJPY+0.56%GBPCAD-0.55%CADCHF+0.55%EURUSD-0.51%GBPTRY+0.41%USDCHF+0.40%GBPUSD-0.39%GBPHKD+0.32%GBPMXN-0.28%USDTRY+0.27%AUDUSD+0.26%USDMXN+0.22%CHFJPY+0.17%GBPJPY+0.16%USDILS+0.16%EURSGD-0.15%NZDMXN+0.14%USDCAD-0.14%NZDSGD-0.13%PLNJPY-0.13%USDCNH-0.13%EURCHF-0.12%GBPSGD-0.12%USDTHB-0.12%EURCNH-0.12%EURGBP-0.11%CHFSGD-0.11%AUDCAD+0.10%AUDSGD-0.08%EURNOK-0.08%EURHKD-0.08%USDDKK+0.07%USDSGD-0.07%EURCZK+0.07%USDPLN+0.07%EURJPY+0.06%AUDDKK+0.06%USDZAR+0.06%NOKJPY-0.05%USDHKD+0.05%USDCOP-0.04%CHFNOK-0.04%USDSEK+0.04%EURSEK-0.04%EURZAR-0.02%AUDNOK-0.02%SGDJPY+0.01%CHFSEK+0.01%USDNOK-0.01%GBPZAR+0.01%EURPLN0.00%EURDKK0.00%GBPCHF0.00%GAGUSD-1.37%XAGUSD-1.37%XPTUSD-1.33%XAUUSD-0.72%GAUUSD-0.72%XNGUSD+0.68%USOIL-0.62%HG1-0.40%UKOIL-0.40%C1+0.39%S1-0.33%COTTON-0.09%BTCUSD-1.10%ETHUSD+22.55%USDTUSD+0.01%XRPUSD+12.79%SOLUSD+16.94%TRXUSDT-0.05%ZECUSDT-5.10%DOGEUSD+18.62%XMRUSDT-3.26%LINKUSD+23.58%BCHUSDT-5.92%XLMUSD-1.22%UNIUSD-0.97%LTCUSD+16.21%SUIUSD-2.62%HBARUSDT-3.44%TONUSD+39.55%TAOUSDT-2.91%AAVEUSD-2.97%DOTUSDT-2.60%ICPUSDT-2.20%ONDOUSDT-3.26%WLDUSDT-5.81%ARBUSDT-1.27%JUPUSDT-4.67%ATOMUSDT-1.92%INJUSDT-4.61%STXUSDT-9.61%TIAUSDT-1.17%FETUSDT-2.49%PYTHUSDT-3.59%SEIUSDT-2.68%IMXUSDT-2.50%GRTUSDT-4.46%OPUSDT-2.98%WIFUSDT-0.83%IOTAUSDT-6.27%POLUSDT-2.31%AXSUSDT-4.14%EOSUSDT-1.33%FARTCOINUSDT-3.35%DYDXUSDT-2.29%GALAUSDT-1.53%ORDIUSDT-3.18%RONINUSDT-4.54%NOTUSDT-2.42%NVDA-0.69%AAPL+0.50%GOOGL+1.34%MSFT+2.72%AMZN-0.62%TSM+0.60%SPCX-2.25%AVGO+2.77%TSLA-0.63%META+0.54%LLY+0.50%SKHY+13.30%BRK-B-0.49%MU-2.54%WMT-0.46%AMD+3.24%JPM+1.05%XOM+1.17%V-0.31%JNJ+0.86%ASMLa+1.33%MA+0.08%ABBV-0.14%INTC+1.91%1398.HK+2.46%CVX+0.46%0700.HK-1.52%ORCL+10.58%COST-0.95%CSCO-0.98%KO+0.60%PG-0.61%UNH-0.80%1816.HK-24.73%BAC+0.34%3988.HK+1.86%AMAT+5.07%AP2d+4.38%CAT+0.01%0857.HK+3.02%LRCX+5.39%HD-0.30%PM+0.01%0939.HK+2.47%DELL-1.64%GE+1.17%1288.HK+1.81%0005.HK+0.34%MS+1.81%HSBA.L+0.09%AUDNZD+1.65%NZDCAD-1.54%NZDUSD-1.38%GBPNZD+1.01%NZDCHF-0.98%EURNZD+0.87%NZDJPY-0.83%AUDJPY+0.82%EURAUD-0.76%CADJPY+0.73%AUDCHF+0.67%EURCAD-0.64%GBPAUD-0.64%USDJPY+0.56%GBPCAD-0.55%CADCHF+0.55%EURUSD-0.51%GBPTRY+0.41%USDCHF+0.40%GBPUSD-0.39%GBPHKD+0.32%GBPMXN-0.28%USDTRY+0.27%AUDUSD+0.26%USDMXN+0.22%CHFJPY+0.17%GBPJPY+0.16%USDILS+0.16%EURSGD-0.15%NZDMXN+0.14%USDCAD-0.14%NZDSGD-0.13%PLNJPY-0.13%USDCNH-0.13%EURCHF-0.12%GBPSGD-0.12%USDTHB-0.12%EURCNH-0.12%EURGBP-0.11%CHFSGD-0.11%AUDCAD+0.10%AUDSGD-0.08%EURNOK-0.08%EURHKD-0.08%USDDKK+0.07%USDSGD-0.07%EURCZK+0.07%USDPLN+0.07%EURJPY+0.06%AUDDKK+0.06%USDZAR+0.06%NOKJPY-0.05%USDHKD+0.05%USDCOP-0.04%CHFNOK-0.04%USDSEK+0.04%EURSEK-0.04%EURZAR-0.02%AUDNOK-0.02%SGDJPY+0.01%CHFSEK+0.01%USDNOK-0.01%GBPZAR+0.01%EURPLN0.00%EURDKK0.00%GBPCHF0.00%GAGUSD-1.37%XAGUSD-1.37%XPTUSD-1.33%XAUUSD-0.72%GAUUSD-0.72%XNGUSD+0.68%USOIL-0.62%HG1-0.40%UKOIL-0.40%C1+0.39%S1-0.33%COTTON-0.09%BTCUSD-1.10%ETHUSD+22.55%USDTUSD+0.01%XRPUSD+12.79%SOLUSD+16.94%TRXUSDT-0.05%ZECUSDT-5.10%DOGEUSD+18.62%XMRUSDT-3.26%LINKUSD+23.58%BCHUSDT-5.92%XLMUSD-1.22%UNIUSD-0.97%LTCUSD+16.21%SUIUSD-2.62%HBARUSDT-3.44%TONUSD+39.55%TAOUSDT-2.91%AAVEUSD-2.97%DOTUSDT-2.60%ICPUSDT-2.20%ONDOUSDT-3.26%WLDUSDT-5.81%ARBUSDT-1.27%JUPUSDT-4.67%ATOMUSDT-1.92%INJUSDT-4.61%STXUSDT-9.61%TIAUSDT-1.17%FETUSDT-2.49%PYTHUSDT-3.59%SEIUSDT-2.68%IMXUSDT-2.50%GRTUSDT-4.46%OPUSDT-2.98%WIFUSDT-0.83%IOTAUSDT-6.27%POLUSDT-2.31%AXSUSDT-4.14%EOSUSDT-1.33%FARTCOINUSDT-3.35%DYDXUSDT-2.29%GALAUSDT-1.53%ORDIUSDT-3.18%RONINUSDT-4.54%NOTUSDT-2.42%
CA

CareDx, Inc (CDNA)

NASDAQ • Healthcare

$72.13
+$1.59 (+2.3%)
Market closed

Last close at October 28, 2026 at 20:00 UTC

Open$69.91
Day Range$69 - $73.43
Avg. Volume (3M)1.3M
Market Cap$3.7B
P/E Ratio33.5
52 Week Range
$14.23$73.43
Next EarningsTodayOct 29, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$131.9M100%
Gross Profitminus cost of goods$96.9M74%
Operating Incomeminus R&D and overhead$257K0%
Net Incomeminus taxes and the rest$110.6M84%

In plain terms: out of every $100 in revenue, CareDx, Inc keeps $84 as net profit.

Fundamentals & Financials

Revenue (TTM)
$458M
Net Income (TTM)
$111M
EPS (TTM)
$2.15
ROA (TTM)
20.83%
Current Ratio
4.58
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+503.0%Q1 2026$0.12
+209.1%Q2 2026$0.34
+59.4%Q3 2026$0.37
Next

Oct 29

todayQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +59.4%

CareDx topped expectations on both the top and bottom line in the second fiscal quarter of 2026, which it reported on July 30, 2026, as revenue rose 52.2% to roughly $131.9 million (up from about $86.7 million a year ago) alongside adjusted EPS of $0.37 versus -$0.16 a year ago. On the consensus comparison, adjusted EPS of $0.37 topped the $0.23 estimate (+59%), while revenue of $131.9 million topped the $114.0 million estimate (+15.7%). The transplant-focused diagnostics and research software provider generated gross profit of about $97.0 million, with gross margin at roughly 74%, and it produced operating cash flow of about $30.6 million. For the next period, consensus calls for EPS of $0.24 on revenue of $121.9 million.

Next report — what to expect

CareDx, Inc (CDNA) is set to report earnings on November 3, 2026. Wall Street is looking for consensus EPS of $0.24 on consensus revenue of $122.0 million. For trailing context, revenue grew +52.2% year over year last quarter. CareDx has beaten EPS in 7 of 8 most recent quarters.

View full earnings history

About CareDx, Inc

CareDx, Inc. trades on the NASDAQ as CDNA and operates in transplant-focused medical diagnostics and research software. The company develops diagnostic and management tools for transplant recipients, serving healthcare providers globally through direct sales and distributor networks, and generated $379.8 million of revenue in FY2025.

Name
CareDx, Inc
CEO
John Walter Hanna Jr.
Website
www.caredx.com
Industry
Healthcare
Year Founded
1998
Employees
763

Today's Snapshot

AI-generated

CDNA closed 2.3% higher at 72.13, close to its 52-week high of 73.43. CareDx showcased data for AlloSure Kidney, its transplant-monitoring test. CDNA is due to report earnings on 29 October.

Trading Volume

Below 10d avg (1.1M)

904.1K

vs S&P 500 Today

Outperforming Market

+2.00%

Updated: October 28, 2026 at 20:15 UTC

Technical Indicators

6 Buy2 Neutral0 Sell
CDNA shows a clear bullish technical profile driven by strong trend confirmation and positive momentum, with the ADX signaling a robust directional move and MACD and CCI both indicating buying pressure while the RSI sits just below overbought. The current price is trading well above short- and medium-term moving averages and massively above the 200-day level, and OBV reflects supportive volume accumulation. Volatility is elevated, with a multi-percent ATR relative to price, while the pivot sits just below the market. Technical takeaway: Strong Buy — broad trend and momentum indicators are aligned in favor of the upside.
All signals
  • EMA (5 indicators)$37.50 - $68.95
    Buy
  • RSI (14)68.73
    Neutral
  • Stochastic %K (14, 3, 3)79.66
    Neutral
  • MACD Level (12, 26)3.47
    Buy

Peers & Related Assets

NTRANatera, Inc.
$424.42+3.3%
QGENQiagen N.V.
$50.33+0.3%
VCYTVeracyte, Inc.
$50.31+0.1%
WGSGeneDx Holdings Corp.
$64.69+3.1%
MYGNMyriad Genetics, Inc.
$6.63+5.4%
FLGTFulgent Genetics, Inc.
$21.52+4.0%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.